Magnum Opus Life Sciences LLP
About Magnum Opus Life Sciences LLP
Data last updated:
Magnum Opus Life Sciences LLP is a limited liability partnership (LLP) based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 June 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Jaipur, under LLPIN AAG-7706. Its GSTIN is 07ABDFM1858J1Z2 (Delhi). The LLP holds 2 GST registrations, all of them active.
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Harvinder Singh and Arun Narang.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Jaipur, Rajasthan.
As per MCA filings, the LLP has open charges of ₹1.9 Cr on record. Court records list 1 case involving the LLP, including 1 filed against it.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No D – 109, Kevat Marg Pawan Path Hanuman Nagar, Jaipur, Rajasthan, India – 302021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Magnum Opus Life Sciences LLP FY 2024 filings available
Financial Statement Summary of Magnum Opus Life Sciences LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Magnum Opus Life Sciences LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Magnum Opus Life Sciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Magnum Opus Life Sciences LLP
Magnum Opus Life Sciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harvinder Singh | Designated Partner | 24 Jun 2016 | 10 Years 3 Months | Current |
| Arun Narang | Designated Partner | 24 Jun 2016 | 10 Years 3 Months | Current |
Charges & Borrowings of Magnum Opus Life Sciences LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2025 | Yes Bank Limited | ₹1.9 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Magnum Opus Life Sciences LLP
Magnum Opus Life Sciences LLP has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Civil suit | Filed against the company by State | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Magnum Opus Life Sciences LLP
Employment history and EPFO contributions of people linked to Magnum Opus Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Magnum Opus Life Sciences LLP
Magnum Opus Life Sciences LLP has 4 designated partner changes on record since 2016: 3 appointments and 1 cessation. The latest: Suman Kumawat ceased to be Designated Partner on 20 Jun 2024.
Credit Ratings, Litigation & Regulatory Alerts for Magnum Opus Life Sciences LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Magnum Opus Life Sciences LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Magnum Opus Life Sciences LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Magnum Opus Life Sciences LLP
Magnum Opus Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABDFM1858J1Z2 | Delhi | Active | 01 Jul 2017 |
| 08ABDFM1858J1Z0 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Magnum Opus Life Sciences LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magnum Opus Life Sciences LLP
Magnum Opus Life Sciences is an active limited liability partnership based in Jaipur, Rajasthan, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 24 June 2016 (10+ years old) and is registered under LLPIN AAG-7706.
Magnum Opus Life Sciences has 2 current designated partners:
- Harvinder Singh - Designated Partner
- Arun Narang - Designated Partner
The GSTIN of Magnum Opus Life Sciences is 07ABDFM1858J1Z2, registered in Delhi. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08ABDFM1858J1Z0 (Rajasthan).
The LLPIN (Limited Liability Partnership Identification Number) of Magnum Opus Life Sciences is AAG-7706. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Magnum Opus Life Sciences has 1 court case on record: 1 filed against it.
Magnum Opus Life Sciences was incorporated on 24 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
Suman Kumawat ceased to be Designated Partner on 20 Jun 2024. Arun Narang was appointed as Designated Partner on 24 Jun 2016. Harvinder Singh was appointed as Designated Partner on 24 Jun 2016. Magnum Opus Life Sciences has 4 designated partner changes on record in total.
The registered office of Magnum Opus Life Sciences is at Shop No D – 109, Kevat Marg Pawan Path Hanuman Nagar, Jaipur, Rajasthan, India – 302021.
The total obligation of contribution is ₹50,000.
Magnum Opus Life Sciences operates in the pharma industry, in the drug formulation and development segment.